Found: 6
Select item for more details and to access through your institution.
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 5, p. 765, doi. 10.1007/s12185-020-03075-6
- By:
- Publication type:
- Article
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 4, p. 524, doi. 10.1007/s12185-020-02926-6
- By:
- Publication type:
- Article
Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3217
- By:
- Publication type:
- Article
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
- Published in:
- 2020
- By:
- Publication type:
- journal article